Ligand Pharmaceuticals Inc (LGND)
104.78
+2.54
(+2.48%)
USD |
NASDAQ |
Oct 04, 16:00
104.59
-0.19
(-0.18%)
After-Hours: 20:00
Ligand Pharmaceuticals Shareholders Equity (Annual): 700.91M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 700.91M |
| December 31, 2022 | 597.48M |
| December 31, 2021 | 821.16M |
| December 31, 2020 | 709.52M |
| December 31, 2019 | 767.23M |
| December 31, 2018 | 560.91M |
| December 31, 2017 | 418.65M |
| December 31, 2016 | 370.85M |
| December 31, 2015 | 276.91M |
| December 31, 2014 | 26.32M |
| December 31, 2013 | 49.61M |
| December 31, 2012 | 26.48M |
| December 31, 2011 | 8.185M |
| December 31, 2010 | -4.849M |
| December 31, 2009 | 3.744M |
| Date | Value |
|---|---|
| December 31, 2008 | -10.36M |
| December 31, 2007 | 29.12M |
| December 31, 2006 | 27.35M |
| December 31, 2005 | -110.42M |
| December 31, 2004 | -75.32M |
| December 31, 2003 | -37.55M |
| December 31, 2002 | 74.02M |
| December 31, 2001 | -57.88M |
| December 31, 2000 | -55.12M |
| December 31, 1999 | -25.60M |
| December 31, 1998 | -11.40M |
| December 31, 1997 | 34.30M |
| December 31, 1996 | 34.50M |
| December 31, 1995 | 28.10M |
| December 31, 1994 | 26.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
597.48M
Minimum
2022
821.16M
Maximum
2021
719.26M
Average
709.52M
Median
2020
Shareholders Equity (Annual) Benchmarks
| Regeneron Pharmaceuticals Inc | 25.97B |
| Agios Pharmaceuticals Inc | 811.02M |
| ADMA Biologics Inc | 135.21M |
| AnaptysBio Inc | 88.10M |
| Black Diamond Therapeutics Inc | 116.74M |